Characterization of Mucosa-Associated Microbiota in Matched Cancer and Non-neoplastic Mucosa From Patients With Colorectal Cancer
- PMID: 31244818
- PMCID: PMC6581718
- DOI: 10.3389/fmicb.2019.01317
Characterization of Mucosa-Associated Microbiota in Matched Cancer and Non-neoplastic Mucosa From Patients With Colorectal Cancer
Abstract
Colonic microbiota play important roles in the development of colorectal cancer. We aim to characterise the mucosa-associated microbiota in the tumour as well as the matched non-neoplastic mucosa from patients with colorectal cancer. Microbiota profiling in these samples was done using high-throughput 16S rRNA amplicon sequencing. Our results showed that the microbiota richness and diversity were similar between the tumour and non-neoplastic mucosae. Linear discriminant analysis effect size (LEfSe) analysis identified Fusobacterium and Campylobacter as the key genera of the tumour while Brevundimonas as the key genus of the non-neoplastic mucosa. In patients with shorter survival period, the relative abundance of Fusobacterium and Campylobacter was significantly higher in the tumour. Besides, regardless of the sites, tumour showed higher abundance of Fusobacterium. On the other hand, the relative abundance of Brevundimonas was significantly lower in the tumour. When validated with quantitative ddPCR, we found the absolute numbers of both Fusobacterium and F. nucleatum were significantly higher in the carcinoma from patients with shorter survival period, conventional type of adenocarcinoma in the distal portion of the large intestine (descending colon, sigmoidal colon, and rectum). In conclusion, our study showed a compositional alteration in the mucosa-associated microbiota in the tumour, which may contribute to the progression of colorectal cancer.
Keywords: 16S rRNA amplicon sequencing; Brevundimonas; Fusobacterium; colorectal cancer; dysbiosis; mucosa-associated microbiota.
Figures







Similar articles
-
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention.BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000145. doi: 10.1136/bmjgast-2017-000145. eCollection 2017. BMJ Open Gastroenterol. 2017. PMID: 28944067 Free PMC article.
-
The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer.Digestion. 2022;103(2):141-149. doi: 10.1159/000519487. Epub 2021 Oct 7. Digestion. 2022. PMID: 34619680
-
New Insights into Mucosa-Associated Microbiota in Paired Tumor and Non-Tumor Adjacent Mucosal Tissues in Colorectal Cancer Patients.Cancers (Basel). 2024 Nov 29;16(23):4008. doi: 10.3390/cancers16234008. Cancers (Basel). 2024. PMID: 39682194 Free PMC article.
-
Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.Expert Rev Gastroenterol Hepatol. 2015 May;9(5):651-7. doi: 10.1586/17474124.2015.1001745. Epub 2015 Jan 12. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25582922 Review.
-
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. World J Gastroenterol. 2016. PMID: 26811607 Free PMC article. Review.
Cited by
-
Tumor microbiome analysis provides prognostic value for patients with stage III colorectal cancer.Front Oncol. 2023 Oct 26;13:1212812. doi: 10.3389/fonc.2023.1212812. eCollection 2023. Front Oncol. 2023. PMID: 37965445 Free PMC article.
-
Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer.Int J Mol Sci. 2021 Oct 27;22(21):11608. doi: 10.3390/ijms222111608. Int J Mol Sci. 2021. PMID: 34769037 Free PMC article. Review.
-
Genomic alterations in Bacteroides fragilis favor adaptation in colorectal cancer microenvironment.BMC Genomics. 2025 Mar 18;26(1):269. doi: 10.1186/s12864-025-11421-3. BMC Genomics. 2025. PMID: 40102781 Free PMC article.
-
The Application of High-Throughput Technologies for the Study of Microbiome and Cancer.Front Genet. 2021 Jul 28;12:699793. doi: 10.3389/fgene.2021.699793. eCollection 2021. Front Genet. 2021. PMID: 34394190 Free PMC article.
-
Profiling the Bladder Microbiota in Patients With Bladder Cancer.Front Microbiol. 2022 Feb 7;12:718776. doi: 10.3389/fmicb.2021.718776. eCollection 2021. Front Microbiol. 2022. PMID: 35197936 Free PMC article.
References
-
- Alkanany F. N. A., Gmais S. A., Maki A. A., Altaee A. M. R. (2017). Estimation of bacterial biodegradability of PAH in Khor Al-Zubair Channel. South. Iraq. Int. J. Mar. Sci. 7 399–410.
LinkOut - more resources
Full Text Sources
Molecular Biology Databases